Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Update on peritoneal dialysis solutions.

C W McIntyre1

  • 1Division of Vascular Medicine, School of Medical and Surgical Sciences, University of Nottingham Medical School, Derby, UK. Chris.Mclntyre@sdah-tr.trent.nhs.uk

Kidney International
|February 15, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Dialyzer characteristics are associated with differential effects on intradialytic microvascular tissue perfusion.

Annals of medicine and surgery (2012)·2026
Same author

Author Correction: Intravital microscopic observation of the microvasculature during hemodialysis in healthy rats.

Scientific reports·2022
Same author

Intravital microscopic observation of the microvasculature during hemodialysis in healthy rats.

Scientific reports·2022
Same author

Hemodynamic response to non-pneumatic anti-shock compression garments in patients with renal dysfunction.

BMC nephrology·2020
Same author

Successful Reintroduction of Peritoneal Dialysis After Peritoneal-Pericardial Fistula in a Child: A Case Report.

Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis·2018
Same author

High sodium intake is associated with important risk factors in a large cohort of chronic kidney disease patients.

European journal of clinical nutrition·2014
Same journal

Crystal-Storing Histiocytosis Causing Severe AKI.

Kidney international·2026
Same journal

Peritoneal dialysis in a patient with extensive burn scarring.

Kidney international·2026
Same journal

COPA syndrome unmasked by anti-neutrophil cytoplasmic antibody-positive immune-complex nephritis.

Kidney international·2026
Same journal

Monitoring anti-nephrin antibodies in the management of recurrent diffuse podocytopathy.

Kidney international·2026
Same journal

The "Hear My Last Wish" Initiative: Leveraging Voiceprint Technology to Bridge the Gap Between Donor Intent and Family Consent in Taiwan.

Kidney international·2026
Same journal

A three-year randomized, double-blind, placebo-controlled study of lanreotide in stage 2/3 autosomal dominant polycystic kidney disease.

Kidney international·2026
See all related articles

New peritoneal dialysis (PD) solutions enhance biocompatibility and patient experience in chronic kidney disease management. These advancements improve fluid and solute removal, nutritional status, and metabolic derangements compared to conventional PD treatments.

Area of Science:

  • Nephrology
  • Biomaterials Science

Background:

  • Peritoneal dialysis (PD) has evolved from focusing on technique survival to enhancing biocompatibility and managing local and systemic effects.
  • Conventional PD solutions, often glucose-based and lactate-buffered, have limitations impacting patient outcomes.
  • Novel PD solutions represent a significant advancement in managing chronic kidney disease.

Purpose of the Study:

  • To review the characteristics of next-generation PD fluids.
  • To evaluate the potential clinical applications of these novel PD solutions.
  • To assess their impact on peritoneal structure, function, and patient experience.

Main Methods:

  • Review of current literature on novel PD fluid compositions and manufacturing techniques.
  • Analysis of studies investigating the effects of new PD solutions on peritoneal membrane.

Related Experiment Videos

  • Evaluation of clinical data regarding patient outcomes and experience with advanced PD fluids.

    • Main Results:

    • Novel PD solutions offer improved biocompatibility through advanced buffering and osmotic agents.
    • These solutions demonstrate potential for enhanced peritoneal membrane integrity and function.
    • Benefits include improved fluid/solute management, nutritional support, and metabolic profile.

    Conclusions:

    • Next-generation PD fluids hold promise for improving both the local peritoneal environment and systemic health in PD patients.
    • Further outcome-based studies are needed to fully elucidate the long-term benefits and optimal use of these advanced PD solutions.
    • Personalized selection of PD fluids may be key to maximizing patient benefits and outcomes.